Massachusetts Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Healthcare Journal.

Press releases published on March 11, 2026

Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
QMENTA Appoints Dr. Montserrat Barceló as Strategic Advisor to Support Global Growth and Enterprise Expansion
Human Appeal's #ForMama26 Campaign to Save only Maternity Hospital in Northwest Syria
BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
Cosmos Health Purchases $600,000 of Bitcoin, Expands Digital Asset Holdings to $3,100,000
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
GUERBET : 2025 full-year results.
GUERBET : Résultats annuels 2025.
Dr. Ranjan Rajbanshi Establishes New Academic Scholarship for Aspiring Medical and Healthcare Professionals to Support Future Clinical Excellence
Io Therapeutics, Inc. announces publication of studies on the company’s RXR agonist compound IRX4204 for breast cancer prevention
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite
Bigelow Tea Partners in Exciting New NIL Deal
Walk More to Stress Less: Get Moving to Improve Well-Being
Premom’s Doctor-Formulated Sperm Fortify Wins 2026 Best New Product Award from BrandSpark and Newsweek
Toro Neurovascular Announces FDA 510(k) Clearance for Toro 88 Superbore Catheter
HairClub Unveils New Brand Identity and Advertising Under New CMO
SIGGY Releases 'Wirehead' Album Created from Neural Signals by Neuroscientist Dr. Galen Buckwalter
Nelipak Announces Opening of Asia-Pacific Technical Development Center
PolTREG treibt das europäische Zulassungsverfahren für die TREG-Therapie bei Typ-1-Diabetes voran
PolTREG poursuit la procédure d’enregistrement au niveau européen de sa thérapie à base de TREG destinée au traitement du diabète de type 1

Share this page:

Sign up for:

Massachusetts Healthcare Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.